Larvol Delta - A-Study-to-Investigate-Efficacy-Tolerability-and-Safety-of-ABY035-in-Patients-With-Active-Psoriatic-Arthritis

izokibep (ABY-035) - Affibody, ACELYRIN

http://clinicaltrials.gov/ct2/show/NCT04713072

Feb 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next